Activation of PPARg inhibits DA-dependent oICSS, while blockade of PPARa and PPARg attenuates Δ9-THC-induced reward-attenuation (aversion) and anxiety but potentiates Δ9-THC-induced hypoactivity and catalepsy. Here, PPARG is linked to Anxiety.